SCHEMBL31095342

SCHEMBL31095342

Clc1nc(Nc2cn(-c3ccccc3)cn2)c2scc(Br)c2n1

nearest known ligand 0.60

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ACVR1 Q04771 10/20 0.60
▸ PAK4 O96013 1/20 0.40
▸ WDR5 P61964 1/20 0.38
▸ JAK2 O60674 1/20 0.32
▸ JAK3 P52333 1/20 0.32
▸ CCNA2 P20248 1/20 0.32
▸ CDK2 P24941 1/20 0.32
▸ CCNA1 P78396 1/20 0.32
▸ CDK5 Q00535 1/20 0.32
▸ DYRK1A Q13627 1/20 0.32
▸ CDK5R1 Q15078 1/20 0.32
▸ CYP2D6 P10635 1/20 0.32
▸ CYP2C9 P11712 1/20 0.32
▸ TSHR P16473 1/20 0.32
▸ CYP2C19 P33261 1/20 0.32
▸ NPC1 O15118 1/20 0.32
▸ RAB9A P51151 1/20 0.32
▸ NLRP3 Q96P20 1/20 0.32
▸ HTR2C P28335 1/20 0.30
▸ YTHDC1 Q96MU7 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25221943 1.00 ACVR1 (0.60) ACVR1PAK4WDR5JAK2JAK3
SCHEMBL25196046 0.90 ACVR1 (0.50) ACVR1PAK4WDR5JAK2JAK3
SCHEMBL25195068 0.80 ACVR1 (0.65) ACVR1PAK4WDR5JAK2CDK5
SCHEMBL25201204 0.77 ACVR1 (0.47) ACVR1PAK4WDR5CCNA2CDK2
SCHEMBL20589604 0.76 ACVR1 (1.00) ACVR1
SCHEMBL20589159 0.76 ACVR1 (1.00) ACVR1
SCHEMBL31095382 0.76 ACVR1 (1.00) ACVR1
SCHEMBL25212165 0.75 ACVR1 (0.62) ACVR1PAK4WDR5CYP2D6CYP2C9
SCHEMBL20589975 0.75 ACVR1 (0.61) ACVR1PAK4WDR5JAK2JAK3
SCHEMBL31095453 0.75 ACVR1 (0.61) ACVR1PAK4WDR5JAK2JAK3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-119060060-A Imidazole-containing ALK2 kinase inhibitors 拜奥克里斯特制药公司 2024-12-03 — — CN disclosed
CN-110913855-B Imidazole-containing ALK2 kinase inhibitors 拜奥克里斯特制药公司 2024-09-03 — — CN disclosed
Send feedback